Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2025 04:17 ET | Source: Telix Pharmaceuticals Limited

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix Pharmaceuticals reported strong Q1 2025 revenue of $186 million, up 62% year-on-year, driven by Illuccix® sales and RLS Radiopharmacies acquisition.
October 29, 2019 19:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals and AusHealth to Partner on Novel Therapeutics for Lung, Ovarian Cancer

MELBOURNE, Australia and ADELAIDE, Australia, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) has today announced that Telix and AusHealth have entered into a collaboration...
August 29, 2019 20:00 ET | Source: Telix Pharmaceuticals Limited

Telixが日本で腎臓がん用画像診断薬の臨床治験を開始

メルボルン, オーストラリアおよび京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
August 29, 2019 20:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study

MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
August 07, 2019 20:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals and GenesisCare Commence ENHANCING Prostate Cancer Clinical Study

MELBOURNE, Australia and SYDNEY, Australia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on...